KLK3 and prostate cancer: Our observation of worse prostate cancer outcome following the 2012 USPSTF's recommendation against PSA-based screening is consistent with that of previous studies, which report that the USPSTF’s 2012 PSA screening recommendation has had profound effects on the presentation and management of prostate cancer.